Role of TGF-β in proliferative vitreoretinal diseases and ROCK as a therapeutic target
Year: 2008
Type: article
Abstract: Cicatricial contraction of preretinal fibrous membrane is a cause of severe vision loss in proliferative vitreoretinal diseases such as proliferative diabetic retinopathy (PDR) and proliferative vitreoretinopathy (PVR). TGF-beta is overexpressed in the vitreous of patients with proliferative vitreoretinal diseases and is also detectable in the contractile membranes. Therefore, TGF-beta is presumed to contribute to the cicatricial contraction of the membranes, however, the underlying mechanisms and TGF-beta's importance among various other factors remain to be elucidated. Vitreous samples from PDR or PVR patients caused significantly larger contraction of hyalocyte-containing collagen gels, compared with nonproliferative controls. The contractile effect was strongly correlated with the vitreal concentration of activated TGF-beta2 (r = 0.82, P < 0.0001). PDR or PVR vitreous promoted expression of alpha-smooth muscle actin (alpha-SMA) and phosphorylation of myosin light chain (MLC), a downstream mediator of Rho-kinase (ROCK), both of which were dramatically but incompletely suppressed by TGF-beta blockade. In contrast, fasudil, a potent and selective ROCK inhibitor, almost completely blocked the vitreous-induced MLC phosphorylation and collagen gel contraction. Fasudil disrupted alpha-SMA organization, but it did not affect its vitreal expression. In vivo, fasudil significantly inhibited the progression of experimental PVR in rabbit eyes without affecting the viability of retinal cells by electroretinographic and histological analyses. These results elucidate the critical role of TGF-beta in mediating cicatricial contraction in proliferative vitreoretinal diseases. ROCK, a key downstream mediator of TGF-beta and other factors might become a unique therapeutic target in the treatment of proliferative vitreoretinal diseases.
Language: English
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: Research to Prevent Blindness, Eye Bank Association of America, Asahi Kasei Pharma Corporation, Japan Eye Bank Association, National Institutes of Health, Japan Society for the Promotion of Science, National Heart, Lung, and Blood Institute, National Eye Institute, National Institute of Allergy and Infectious Diseases
Awards: Investigation of the pathogenesis of proliferative vitreoretinal diseases and development of new drug therapy, Mechanisms of Selectin Shedding in Leukocyte Recruitment, 酵素を用いたケミカルビトレクトミーの基礎及び臨床研究, Examination for new possibility and the clinical application of the new ophthalmic operation abjuvant, Role of Sialidase in Pulmonary Host Defenses and Acute Lung Injury, P30 Core Grant for Vision Research
OpenAlex ID: W2009959180
